Nu Skin (NUS) has dropped 44% since China’s People Daily alleged that the company’s selling practices amounted to a pyramid scheme. Yet even as Nu Skin drops again today, the conversation is turning back to where it belongs–to Herbalife (HLF) and what Nu Skin’s troubles mean for William Ackman’s bet against seller of nutrition products.
Bloomberg NewsIn “China’s Nu Skin probe may help Ackman’s Herbalife Bet,” Reuters sent a reporter to find out–despite the fact that Herbalife’s 12% three-day drop suggests it already has. From Reuters:
For some investors and academics, the Nu Skin scrutiny raised the chances that Chinese regulators might soon broaden their probe to look into Herbalife, whose global operations include�China.
“The�business�models of these two companies, Nu Skin and Herbalife, are absolutely similar,” said William Keep, dean of the School of Business at the College of New Jersey, who has written extensively on multi-level�marketing. “And it would not be a large leap for Chinese officials to make that they should also look at investigating Herbalife.”
10 Best Shipping Stocks To Buy For 2015: Maximus Inc (MMS)
MAXIMUS, Inc., incorporated on October 18, 2007, provides business process services (BPS) to government health and human services agencies under its mission of Helping Government Serve the People. The Company is primarily focused on operating government-sponsored programs, such as Medicaid, Children's Health Insurance Program (CHIP), health insurance exchanges and other health care reform initiatives, Medicare, welfare-to-work, child support services and other government programs.
The Company is one of the pure-play health and human services administrative providers to governments in the United States, Australia, Canada, the United Kingdom and Saudi Arabia. The Company�� segments include Health Services and Human Services. Effective July 1, 2013, MAXIMUS, Inc. acquired Health Management Ltd.
Health Services Segment
The Company's Health Services segment provides a variety of business process services, as well as related consulting services, for state, provincial and federal government programs, including Medicaid, CHIP, SNAP (Supplemental Nutrition Assistance Program), Medicare, the Affordable Care Act and Health Insurance BC (British Columbia). In this segment, the Company's BPS and consulting services include government health insurance program administration; Health insurance program eligibility and enrollment services to improve access to health care for citizens and help beneficiaries make the best choice for their health insurance coverage; Eligibility and enrollment modernization for government health benefit programs; Health insurance exchange design and operations; Consumer outreach and education, including multilingual customer contact centers and multi-channel self-service options, such as Web-based portals, for easy enrollment; Application assistance and independent enrollment counseling to beneficiaries; Premium payment processing and administration, such as invoicing and reconciliation; Objective, evidence-based health appeals; Independent medical! reviews; Health plan oversight; eHealth solutions with the Medigent product suite; Medicaid Management Information System (MMIS) planning and oversight, and Specialized program consulting services.
Human Services Segment
The Company's Human Services segment provides federal, national, state and county human services agencies with a variety of business process services, as well as related consulting services for welfare-to-work, child support, higher education and K-12 special education programs. The Company's services include welfare-to-work services, including eligibility determination, case management, job-readiness preparation, job search and employer outreach, job retention and career advancement, and selected educational and training services, to help disadvantaged individuals transition from government assistance programs to sustainable employment and economic independence; Full and specialized child support case management services, customer contact center operations, and program and systems consulting services; Management tools and professional consulting services for higher education institutions; K-12 special education case management solutions; Program consulting services, including independent verification and validation, cost allocation plans, repeatable management services and other specialized consulting offerings, and Tax credit and employer services.
The Company competes with Serco, Atos Origin and Ingeus.
Advisors' Opinion:- [By Dan Caplinger]
Dow 16,000, S&P 1,800, and Nasdaq 4,000 didn't become reality today, but each of these benchmarks came close to reaching those respective levels as investors continued to respond favorably to the macroeconomic and monetary-policy environment going forward. But despite the market's broad gains, Electronic Arts (NASDAQ: EA ) , Maximus (NYSE: MMS ) , and Western Union (NYSE: WU ) gave up ground today with fairly substantial drops. Let's take a closer look at why these stocks bucked the market's favorable trend today.
- [By Hilary Kramer]
This is where one of my favorite plays on the healthcare reform comes in. Maximus (MMS) provides cost-effective processing services to government health and human services agencies in the United States, Canada, United Kingdom, Australia and Saudi Arabia. One of its main focuses is healthcare, providing administrative services for many programs, including Medicaid, Children’s Health Insurance Program (CHIP) and Medicare.
- [By Michael Flannelly]
Analysts at Jefferies initiated coverage on business process services provider Maximus Inc. (MMS) late on Thursday, giving the stock a bullish rating because it has several competitive advantages and should benefit from the Affordable Care Act (Obamacare).
The analysts rate MMS as “Buy” and see shares reaching $47. This price target suggests a 20% upside to the stock’s Thursday closing price of $39.14.
“MMS is a leading government outsourced contractor that produces consistently strong results,” Jefferies analyst David Styblo commented. “The company has several competitive advantages and is highly focused on health and human service projects. This positions MMS to enjoy multi-year growth from the ACA and other opportunities with limited risk. The company’s predictable business model, solid balance sheet, and EPS visibility into FY2014 also support a Buy and $47 PT.”
Maximus shares were inactive during pre-market trading on Friday. The stock is up 23.83% year-to-date.
Top 10 Investments For 2014: Market Vectors Steel ETF (SLX)
Market Vectors Steel ETF (the Fund) seeks to replicate as closely as possible the price and yield performance of the NYSE Arca Steel Index (STEEL or the Index) by investing in a portfolio of securities that generally replicates STEEL. STEEL, calculated by the NYSE Alternext, is a modified market capitalization-weighted index consisting of publicly traded companies predominantly involved in the production of steel products or mining and processing of iron ore. The Index includes companies primarily involved in a variety of activities related to steel production, including the operation of manufacturing mills and fabrication of steel products. Companies eligible for inclusion in Index should be engaged in solar power and related products and services, deriving at least 66% of revenues from it with market cap exceeding $100 million, and should have three-month trading volume equal to or greater than $1 million per day. Its investment advisor is Van Eck Associates Corporation. Advisors' Opinion:- [By John Udovich]
On Monday, Goldman Sachs upgraded the whole steel sector from Cautious to Neutral and specifically upgraded small cap and mid cap steel stocks AK Steel Holding Corporation (NYSE: AKS), United States Steel Corporation (NYSE: X) and Steel Dynamics Inc. (NASDAQ: STLD) to Buy with price targets of $6, $30 and $22, respectively, but should you go for one of these individual steel stocks or for the Market Vectors Steel ETF (NYSEARCA: SLX)? To begin with, Goldman Sachs says that the�supply-demand fundamentals for steel are starting to look more appealing as some supply has been taken out plus they have a very bearish view on input costs (as in iron ore)���which bodes well for steel producers in the long run. Moreover, recently filed trade cases could provide some tailwind���if they are successful.�Of course a rising tide can lift all ships, but Goldman Sachs suggests that you go for the following�small cap or mid cap steel stocks:�
- [By Ben Levisohn]
In our late October report on X, we noted the Company was “scratching the surface” on operational improvement, and we expected shares to edge higher over the near term. While X shares have appreciated by 16% since that report vs. the S&P 500 of +4% and the [Market Vectors Steel ETF (SLX)] of +3%, we believe shares have more room to run based on our positive carbon hot-rolled steel pricing revisions for 2014: meaningful raw material cost tailwinds (coal, scrap, iron ore); low Street EPS and EBITDA expectations for 2014-2015; an ever-increasing interest rate environment (benefits for pension exposure); more evidence of European macro stability; and above-average likelihood of incremental operational efficiency announcements such as a joint venture or tolling agreement with Allegheny Technologies Incorporated (ATI).
Top 10 Investments For 2014: G&K Services Inc (GK)
G&K Services, Inc., incorporated on December 1, 1934, provides branded uniform and facility services programs. The Company serves a base of approximately 170,000 customers. The Company serves customers in all industries, including automotive, warehousing, distribution, transportation, energy, manufacturing, food processing, pharmaceutical, retail, restaurants, hospitality, government, healthcare and many others. The Company provides service to customers of almost every size, from Fortune 100 companies to small and midsize firms. The Company has one million people within its customer base who wear G&K work apparel every work day. In January 2014, the Company announced that it has sold its direct sale program business.
The Company's customer focused relationships involve customers renting or directly purchasing uniforms and providing facility products and services to meet a variety of critical needs in the workplace, including Image, Organization safety and security, Brand awareness, Employee retention, Employee protection and Product protection. The Company also offers facility services programs that provide a range of dust control, maintenance, hand care and hygiene products and services. They include floor mat offerings (traction control, logo, message, scraper, anti-fatigue), towel products (shop, kitchen, bar, bath, dish, continuous roll, microfiber), mop offerings (dust, microfiber, wet), fender covers, selected linen items and restroom hygiene products. The Company's providing of regularly scheduled weekly service of these products and services helps the Company's customers maintain a clean, safe and attractive environment within their facilities for their employees and customers.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on G&K Services (Nasdaq: GK ) , whose recent revenue and earnings are plotted below.
Top 10 Investments For 2014: ResMed Inc (RMD)
ResMed Inc., (ResMed), incorporated on March 31, 1994, is a holding company for the ResMed Group. The Company, through its subsidiaries, is a developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. Sleep-disordered breathing (SDB) includes obstructive sleep apnea (OSA), and other respiratory disorders that occur during sleep. The Company has developed a number of products for SDB and other respiratory disorders including airflow generators, diagnostic products, mask systems, headgear and other accessories. Its manufacturing operations are located in Australia, Singapore, France, Germany, Malaysia and the United States. Its distribution and sales sites are located in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Japan, Norway and Sweden. In December 2013, ResMed Inc acquired Unimedis SRO, a surgical appliance and manufacturing company.
Air Flow Generators
The Company produces continuous positive airway pressure (CPAP), variable positive airway pressure (VPAP) and AutoSet systems for the titration and treatment of SDB. The flow generator systems deliver positive airway pressure through a patient interface, either a small nasal mask, nasal pillows system, or full-face mask. Its VPAP units deliver bilevel therapy. There are two preset pressures: a higher pressure as the patient breathes in, and a lower pressure as the patient breathes out. AutoSet systems are based on a technology to monitor breathing and can also be used in the diagnosis, treatment and management of OSA. The Company�� Stellar 100 and 150 ventilation devices, provide both invasive and non invasive ventilation applications for adult and pediatric patients.
ResMed Inc.�� CPAP products include S8 Escape, S9 Elite and S9 Escape. Its VPAP products include VPAP III STA with QuickNav, VPAP S / VPAP IV, VPAP IV ST, S8 Auto 25, VPAP Tx Lab System, S9 VPAP S, S9 VPAP ST! , S9 VPAP Auto, S9 VPAP Adapt, S9 AutoSet CS, S9 Auto 25 and S9 VPAP COPD. The Company�� automatic positive airway pressure products include S9 AutoSet and S9 Escape Auto. Its ventilation products include Elisee 150, VS III and Stellar 100 and 150.
Masks, Accessories, Motors and Diagnostic Products
Masks, accessories, motors and diagnostic products together accounted for approximately 46% of its net revenues in fiscal 2012. Its Mask products include Activa LT, Swift LT for Her, Swift FX, Mirage SoftGel, Quattro FX, Swift FX for Her, Mirage FX, Mirage FX for Her, Pixi Pediatric Mask, Quattro FX for Her, Swift FX Bella, Quattro Air and Swift FX Nano. Its diagnostic products includes ApneaLink + Oximetry and ApneaLink Plus (U.S.)
Accessories and Other Products
The Company to assist those professionals diagnosing or managing the treatment of patients have data communications and control products, such as the EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. These products include humidifiers, such as H5i and H4i, which connect directly with the CPAP, VPAP and AutoSet flow generators to humidify and heat the air delivered to the patient, helping to prevent the drying of nasal passages that can cause discomfort. Other optional accessories include cold passover humidifiers, carry bags and breathing circuits. The Company�� data/patient management products include S9 Embletta Adapter, ResScan v3.14, ResTraxx v17.1., ResTraxx v18.3, ResScan v3.16 and EasyCare 1.0.
The Company competes with Philips BV, DeVilbiss Healthcare., Fisher & Paykel Healthcare Corporation Limited, Apex Medical Corp, BMC Medical Co. Ltd and Weinmann Gerate fur Medizin GmbH + Co. KG.
Advisors' Opinion:- [By Damian Illia]
A Delaware corporation formed in 1994, ResMed Inc. (RMD) is a global leading designer, developer, manufacturer and marketer of medical products for the diagnosis, treatment and management of sleep-disordered breathing (SDB) and other respiratory disorders. For the quarter ended in Dec. 31, 2013 ResMed reported a 2 percent increase (a 1 percent increase in constant currency basis) in revenue over the quarter ended in Dec. 31, 2012. However, these earnings failed to meet analyst estimates; and not without a reason. A relatively poor performance was expected due to continued pressure in the United States, especially as a consequence of the market's restructuring due to competitive Medicare bidding. This might also be one of the reasons why this stock still remains undervalued.
- [By Roberto Pedone]
Another earnings short-squeeze prospect is medical equipment player ResMed (RMD), which is set to release numbers on Wednesday after the market close. Wall Street analysts, on average, expect ResMed to report revenue of $400.01 million on earnings of 64 cents per share.
The current short interest as a percentage of the float for ResMed is extremely high at 25.6%. That means that out of the 139.26 million shares in the tradable float, 35.89 million shares are sold short by the bears. The bears have also been increasing their bets from the last reporting period by 5%, or by about 1.72 million shares. If the bears get caught pressing their bets into a bullish quarter, then shares of RMD could easily trend sharply higher post-earnings as the shorts rush to cover some of their positions.
From a technical perspective, RMD is currently trending above its 50-day moving average and just below its 200-day moving average, which is neutral trendwise. Shares of RMD have started to flirt with a near-term breakout trade today, since the stock has tested some past overhead resistance at $48.07 a share. That move is starting to push shares of RMD within range of triggering a much bigger breakout trade post-earnings.
If you're bullish on RMD, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some key overhead resistance levels at $51.22 to $51.32 share with high volume. Look for volume on that move that hits near or above its three-month average action of 1.17 million shares. If that breakout hits post-earnings, then RMD will set up to re-fill some of its previous gap-down-day zone from October of 2013 that started just above $56 a share. If that gap gets filled with strong upside volume flows, then RMD could easily trend north of $60 a share.
I would simply avoid RMD or look for short-biased trades if after earnings
- [By Jon C. Ogg]
ResMed�Inc. (NYSE: RMD) was raised to Buy from Neutral at BofA/Merrill Lynch.
Tyson Foods Inc. (NYSE: TSN) was downgraded to Neutral rom Buy at BofA/Merrill Lynch.
- [By Anna Prior]
ResMed Inc.(RMD) seems like a solid growth stock, but March sales reportedly were aided by a quarter-end deal with a large customer, while profit was boosted by noncash accruals, according to Barron’s. The strains evident in march-quarter results may grow, if Medicare and other insurers decide to pay a bundled price for continuous positive airway pressure treatments. Shares slipped 3.8% to $50.49 in recent trading.
Top 10 Investments For 2014: United States Steel Corporation(X)
United States Steel Corporation produces and sells steel mill products in North America and Central Europe. It operates in three segments: Flat-rolled Products (Flat-rolled), U. S. Steel Europe (USSE), and Tubular Products (Tubular). The Flat-rolled segment offers slabs, rounds, strip mill plates, sheets, and tin mill products, as well as iron ore and coke. This segment serves service center, conversion, transportation, construction, container, and appliance and electrical markets in North America. The USSE segment offers slabs, sheets, strip mill plates, tin mill products, and spiral welded pipes, as well as heating radiators and refractory ceramic materials. This segment serves the European construction, service center, conversion, container, transportation, and appliance and electrical, as well as and oil, gas, and petrochemical markets. The Tubular segment offers seamless and electric resistance welded steel casing and tubing; and standard, and line pipe and mechanical tubing. It primarily serves customers in the oil, gas, and petrochemical markets. The company also provides transportation services, including railroad and barge operations. In addition, it owns, develops, and manages various real estate assets, which include approximately 200,000 acres of surface rights primarily in Alabama, Illinois, Maryland, Michigan, Minnesota, and Pennsylvania; participates in joint ventures that are developing real estate projects in Alabama, Maryland, and Illinois; and owns approximately 4,000 acres of land in Ontario, Canada. The company was founded in 1901 and is headquartered in Pittsburgh, Pennsylvania.
Advisors' Opinion:- [By Brian Stoffel]
5. U.S. Steel (NYSE: X ) , P/E of 124
Shareholders of U.S. Steel, one of America and Europe's largest steel producers, have certainly seen better days. The stock has just 10% of the value it had back in 2008 -- when the developing world hungered for steel. - [By Eric Volkman]
One of the longest-serving top executives at U.S. Steel (NYSE: X ) will soon depart. The company announced that CFO Gretchen Haggerty has served notice that she is to enter retirement later this year, and that it has launched a "comprehensive search" to find a replacement.
Top 10 Investments For 2014: Equinix Inc.(EQIX)
Equinix, Inc. provides data center services for the protection and connection of information assets to enterprises, financial service companies, and content and network service providers worldwide. It connects businesses with partners and customers through a platform of high performance data centers, containing dynamic ecosystems and the broadest choice of networks. The company operates International Business Exchange (IBX) centers, or IBX data centers, across 38 markets in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. Equinix offers data center services, including premium data center co-location; interconnection and exchange services; network connectivity; business continuity; and outsourced IT infrastructure services. The company connects approximately 4,000 enterprises, cloud, digital content, and financial companies, including 680 network service providers to help them grow their businesses, improve application performance, and protect their vita l digital assets. It markets its products and services through direct sales force and channel marketing program. Equinix was founded in 1998 and is headquartered in Redwood City, California.
Advisors' Opinion:- [By Tom Taulli]
Innovation: Innovation is a major priority at AT&T. And so far, it looks like the company is making savvy moves, particularly with its push into the cloud. To this end, AT&T has rolled out NetBond, which involves alliances with top providers like IBM (IBM), Microsoft (MSFT), CSC (CSC) and Equinix (EQIX). But perhaps the most interesting growth initiative is Digital Life, which allows customers to use their smartphones as remote control devices with homes and cars. All in all, the opportunity could be huge, adding another nice revenue stream — AT&T already has agreements with companies like GM (GM), Ford (F), Nissan, Audi, BMW and Tesla (TSLA)
Top 10 Investments For 2014: Delcath Systems Inc.(DCTH)
Delcath Systems, Inc., a development stage company, operates as a specialty pharmaceutical and medical device company. It focuses on cancers in the liver. The company involves in the development and clinical study of the Delcath chemosaturation system. Its clinical trial include a Phase III multi-center study for patients with unresectable metastatic ocular or cutaneous melanoma exclusively or predominantly in the liver; and a multi-arm Phase II clinical trial of the Delcath chemosaturation system with melphalan in patients with primary and metastatic liver cancer, which comprise neuroendocrine tumors, hepatocellular carcinoma, ocular or cutaneous melanoma, and metastatic adenocarcinoma. Delcath Systems, Inc. was founded in 1988 and is based in New York, New York.
Advisors' Opinion:- [By Monica Gerson]
Delcath Systems (NASDAQ: DCTH) is expected to post a Q4 loss at $0.05 per share on revenue of $100.00 thousand.
Emerald Oil (NYSE: EOX) is projected to post a Q4 loss at $0.02 per share on revenue of $18.04 million.
- [By John Udovich]
Biotech in general has been one of the market�� hottest sectors this year thanks to plenty of mostly good news�along with�new IPOs while small cap biotech stocks Delcath Systems (NASDAQ: DCTH), ZIOPHARM Oncology Inc (NASDAQ: ZIOP), Recro Pharma (NASDAQ: REPH), TetraLogic Pharmaceuticals (NASDAQ: TLOG)�and TNI BioTech (OTCMKTS: TNIB) have also produced their share of news�this week or in recent weeks. Just consider the following:
No comments:
Post a Comment